Open an account

MindWalk Holdings

HYFT · NASDAQ

$1.29−$0.03 (−2.27%)TodayMarket closed ·
Prev close $1.32

About HYFT

MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Employees
102
Headquarters
Austin, Texas
Listed
Jan 30, 1987
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
mindwalkai.com

HYFT key statistics

Market cap
60.77M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
338.82K
Volume
241.98K
Open price
$1.32
High today
$1.39
Low today
$1.27
52 Week high
$2.99
52 Week low
$0.99

MindWalk Holdings (HYFT) at a glance

MindWalk Holdings (HYFT) last traded at $1.29, with a market cap of 60.77M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.27 and $1.39. The current price is 1.6% above the day's low and 7.2% below its high.

Volume so far is 241.98K shares, below the average of 338.82K shares a day.

Over the past year MindWalk Holdings has ranged from $0.99 to $2.99, and now sits 15% of the way up that range.

MindWalk Holdings met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q1 FY27 it reported -$0.13 per share against an estimate of -$0.0782.

The average analyst price target is $4.42, 242.6% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $4.42
Low
$3.03
Now
$1.29
High
$5.25

HYFT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 32.3% on average.

  1. Q2 FY25: reported -$0.09 per share against an estimate of -$0.0969
  2. Q3 FY25: reported -$0.01 per share against an estimate of -$0.0816
  3. Q4 FY25: reported -$0.05 per share against an estimate of -$0.051
  4. Q1 FY26: reported -$0.064 per share against an estimate of -$0.0561
  5. Q2 FY26: reported -$0.07 per share against an estimate of -$0.051
  6. Q3 FY26: reported -$0.08 per share against an estimate of -$0.0561
  7. Q4 FY26: reported -$0.08 per share against an estimate of -$0.0748
  8. Q1 FY27: reported -$0.13 per share against an estimate of -$0.0782

HYFT news

  • Press releaseGlobe Newswire

    AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test

  • Press releaseBusiness Wire

    MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

  • Press releaseGlobe Newswire

    Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context

  • Press releaseBusiness Wire

    MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function

  • Press releasePRNewswire

    AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

  • Press releaseBusiness Wire

    MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director

  • Press releaseGlobe Newswire

    Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices

  • Press releaseBusiness Wire

    MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

Similar companies

Companies in the same industry as MindWalk Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.